Professor and Senior Consultant in Nuclear Medicine, Department of Radiology at King Faisal Specialist Hospital and Research Centre, Kingdom of Saudia Arabia. Had been appointed as the Chairman of Radiology Department for eight (8) years from 2011 until 2019.

Dr. Khalsa Al Nabhani is a senior consultant in Nuclear Medicine and Radiology, currently serving as the Head of the Nuclear Medicine and Molecular Imaging Center at the Royal Hospital in Muscat, Oman. She completed her radiology residency and obtained OMSB and FRCR qualifications in Oman, followed by fellowship training in the UK. Dr. Al-Nabhani also directs the Radiology Residency Training program in Oman for the Oman Medical Specialty Board. Her expertise spans various nuclear medicine practices, with a focus on clinical applications, safety protocols, and advanced imaging techniques. She is actively involved in international collaborations, including ongoing IAEA projects.

Dr. Alavi has spent the past 5 decades of his career in developing novel techniques that have substantially influenced the evolution of the discipline of molecular imaging. Among his accomplishments, the introduction of 18F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) has truly revolutionized the field and has allowed this powerful modality to expand to daily practice of medicine worldwide. The impact of using FDG-PET along with CT and MRI in managing so many serious diseases and disorders is unparalleled by any other technique in recent history. He has received many awards for his outstanding contributions to the field of molecular imaging. Currently, he is actively involved in conducting research on a full-time basis.

Dr Irfan Kayani is a Consultant Radiologist and Nuclear Medicine Physician working at University College Hospital, London. At UCLH he is the Imaging Lead for Early phase trials at the Clinical Research Facility, PET imaging lead for Lymphoma, and Head of the Clinical Department at the Institute of Nuclear Medicine. The Institute of Nuclear Medicine is one of the largest in United Kingdom and serves as both a National and International Post Graduate Training Centre for Hybrid and Molecular Imaging as a well as a Regional and National Referral Centre for Diagnostics and Theranostics.

Stefan Vöö is Consultant Nuclear Medicine Physician at the Institute of Nuclear Medicine, University College London Hospital and advisor on evidence-based medicine at the National Institute for Health and Care Excellence (NICE) in the UK. Stefan read immunology and medicine at the Ulm University Medical Centre, Germany, demonstrated molecular imaging at the Cardiovascular Research Institute of Maastricht and trained in nuclear medicine and molecular radionuclide therapies at Maastricht University Medical Centre, the Netherlands. He was previously EANM Fellow in molecular imaging at the University Medical Centre, Zürich, Switzerland. His clinical interests are molecular radionuclide therapies & theranostics, imaging in inflammatory and oncological disorders.

Bachelor of medicine with honors from Kuwait University of medicine. Board certified consultant with masters degree in clinical science of Nuclear Medicine. Has a special interest in molecular hybrid imaging particularly after attending a course at Zurich college nuclear medicine in 2010. First to conduct cardiac PET/CT FDG viability protocol in Kuwait at Mubarak Al-Kabeer Hospital. Currently a member of Kuwaiti Board of Nuclear Medicine exam committee in addition to few other committees

GRADUATE OF THE ROYAL COLLEGE OF SURGEONS RCSI,DUBLIN YEAR 2000.
KUWAITI BOARD IN NUCLEAR MEDICINE 2007 MASTERS IN NUCLEAR MEDICINE 2008 FROM KUWAIT UNIVERSITY .
WORKED IN MUBARAK ALKABEER GENERAL HOSPITAL FROM 2003-2007

WORKED IN AMIRI HOSPITAL 2007 -2013
WORKED IN SUBAH ALAHMED UROLOGY CENTER 2013 TILL 2016
CURRENTLY NUCLEAR MEDIINE CONSULTANT AT CHEST DISEASE HOSPITAL

Graduated from Kuwait university faculty of Medicine. Underwent post graduate training in Internal Medicine and Cardiology at McGill university, Montreal Canada. Advanced Fellowship training in adult CArdiac, electrophysiology and university of Texas in Houston, McGovern health sciences centre practising CArdiac electrophysiologist involved in the care of patients with inherited cardiac arrhythmias and infiltrative cardiomyopathy

MBBS, MSc (Nuclear Medicine), Ph.D. KBNM, With clinical Experience of more than 15 years in nuclear medicine and PET/CT and radionuclide therapy. I have 70 international publications with 10 experience in development of new radiopharmaceuticals, pre-clinical and clinical research. Main field of interest include molecular imaging, radionuclide therapy, image processing in PET CT using AI.

Dr Gopinath Gnanasegaran is a Consultant Nuclear Medicine Physician at the Royal Free London NHS Foundation Trust, London, UK. Dr Gnanasegaran is trained in Nuclear Medicine in London, gaining an MSc and MD from London University, and completing Nuclear Medicine residency from Guy’s & St Thomas’ Hospital, London, UK. He was appointed Consultant in Nuclear Medicine at Guy’s & St Thomas’ Hospital, London in 2007. He was appointed the first education chair of the British Nuclear Medicine Society, UK. He moved to Royal Free Hospital, London, in 2016. He has written and co-edited several books in Nuclear Medicine, including the widely acclaimed Atlas of Clinical Nuclear Medicine 3rd Eds.

Ramin Sadeghi is a Nuclear Medicine specialist and researcher with more than 20 years of experience in the field.
Main field of research of Ramin Sadeghi is sentinel node mapping and lymphoscintigraphy as well as bone mineral densitometry.
Ramin Sadeghi has more than 200 published articles in prestigious journals.

Reham Shareef pediatrics endocrinologist Mubarak Alkbeer hospital
MD, Pediatric endocrinology fellowship PETCA
Member of European Society for pediatric endocrinology
and member Arab society of pediatric diabetes and endocrinology
Area of research and publication thyroids dyshormonogenesis

POSITIONS
1981-1985 MIR, Physician in Training, Nuclear Medicine, Hospital Universitari Vall d’Hebron.

1983 Staging, Hospital for Sick Children, Great Ormond Street Hospital, London
1984-1999 Member, Paediatric Committee, EANM
1985-2020 Nuclear Medicine Consultant, Hospital Universitari Vall d’Hebron.
Pediatric Nuclear Medicine, Nephrourology and Radioguided Surgery.
1992-1998 Member, Advisory Council, EANM
1995-1998 Chairperson, Paediatric Committee, EANM
1996-now

1998-2019
Professor, European School Nuclear Medicine and ESMIT

Head, Nuclear Medicine Department, Hospital Delfos

1999-2006 Member, Accreditation Task Group, EANM-UEMS
2000-now Professor, Consultant, IAEA
2001-2009

2001-now
Expert, Oncologic Guides, AATRM

Head, Nuclear Medicine Department, Atrys SIMM

2012-2013

1998-now President, Societat Catalana Medicina Nuclear

Invited lectures: Society of Nuclear Medicine Congresses, EANM Congresses, World Federation of Nuclear Medicine and Biology Congresses, ALASBIMN, IAEA Conferences, WARMTH Congresses, Mubarak Al Kabir Hospital and Ministry of Public Health Kuwait, Dubai Hospital.

HONNORS
Editorial Board:
- EJNMMI
- SNM
- Pediatric Radiology
- REMN

Highlights Lecture, EANM Congress 2009

1st to 11th European Symposium on Paediatric Nuclear Medicine
Organizer and Secretary, 1992-2023.

Paediatric Nuclear Medicine Training Course, Barcelona 2024 October 14-18.

Dr. Ahmad Bushehri is the head of unit C at the department of radiation oncology, Kuwait Cancer Control Center. Part of his responsibilities is head and neck, and thyroid cancers. Ahmad obtained his medical degree from University College Cork, Ireland, he then perused residency and fellowship in radiation oncology at the University of Toronto. He also holds a Master of Health Professions Education degree from Schulich School of Medicine University of Western Ontario.

Author of four books and over 100 peer-reviewed papers, Dr. Usmani is a pioneering figure in the field of nuclear medicine and radionuclide therapy. A graduate of the Nuclear Medicine Board of Kuwait and holding an MSc from Islamabad, Pakistan, he has been instrumental in the development of theranostics, SPECT/CT, and PET/CT technology in Kuwait since the late 2000s. As a consultant nuclear medicine physician at the Sultan Qaboos Comprehensive Care and Research Center in Muscat, Oman, Dr. Usmani played a pivotal role in establishing the first theranostic facility in Oman in 2023, offering 177Lu-DOTATATE and 177Lu-PSMA therapies. His pioneering work in Kuwait includes establishing the 177Lu-PSMA therapy in 2014, a groundbreaking treatment targeting prostate-specific membrane antigen (PSMA) that revolutionized advanced prostate cancer management. He further advanced radionuclide therapy by introducing the highly precise 225Ac-PSMA therapy in 2017 and initiating the 177Lu-DOTATATE therapy for neuroendocrine tumors (NET) in 2019. A Fellow of the European Board of Nuclear Medicine (2007), the Asian Nuclear Medicine Board (2018), and the Royal College of Physicians of Edinburgh (2019), Dr. Usmani served as a teaching staff at the Kuwait Institute of Medical Specialization, Oman Medical Specialty Board and holds an Honorary Senior Lecturer position at Hull York Medical School, United Kingdom. He has been recognized with the Outstanding Doctor Award at the Kuwait Cancer Control Center (2016) and the Most Hardworking House Officer Award at the Department of Medicine, Civil Hospital Karachi, Pakistan (2002). Dr. Usmani has served on the editorial boards of numerous cancer research journals and is currently a review editor for Nuclear Medicine at Frontiers in Medicine. His main research interests lie in bone imaging with 18F-NaF PET/CT in non-oncological indications and 68Ga-PSMA imaging in prostate cancer.

Dr. Alyaa completed here medical education at Kuwait University, gained board certification from the Kuwait Institute of Medical Specialization in nuclear medicine. She perused her PEM training in Bahya hospital in Cairo and recently completed PET/CT fellowship from university of Zurich. Her research contributions include multiple novel PET tracers with high index publication in the field of molecular imaging. She is deeply engaged in the KBNM teaching as head of scientific committee. Dr. Alyaa brings a wealth of experience in hybrid imaging and molecular imaging.

Dr. Ghulam Syed is a nuclear physician with 35 years' experience. He did his residency and training at Kings College Hospital London UK. He also obtained a PhD in Medicine from the University of London, UK. He is diplomat Certification Board of nuclear Cardiology, fellow College of Physicians and Surgeons Pakistan and Fellow, Royal College of Physicians, London.
He has worked in the UK, Pakistan, Kuwait, Saudi Arabia and now heads Molecular Imaging Nuclear Medicine Service at HMC Qatar. He has published over 50 papers and 2 book chapters. He is the Fellowship program Director.

Dr. Alawadhi is a pioneer in radiology and nuclear medicine in Bahrain. He established the Nuclear Medicine Unit at the Ministry of Health in 1995 and has 45 years of experience in the medical field. He served as Chairman of the Radiology and Nuclear Medicine Unit at Salmaniya Medical Complex. In academics, Dr. Alawadhi is a Senior Lecturer at the Arabian Gulf University Medical College. He co-founded the Pan Arab Radiology Board and has held positions such as President of the Bahrain Radiological Association and Bahrain Osteoporosis Society. He has represented Bahrain on the Arab Board and contributed to numerous medical publications. Dr. Alawadhi graduated from Cairo University in 1979, trained in radiology at Royal Victoria Hospital, Belfast (1980–1985), and completed a nuclear medicine fellowship at St. Bartholomew’s, London (1989–1991).

Dr Ahmed Aljizeeri is a Consultant in Adult Cardiology & Advanced Cardiac Imaging at King Abdulaziz Cardiac Center, Ministry of National Guard Health Affairs. He received his medical education at King Saud University and completed his postgraduate education in Internal Medicine, Adult Cardiology, Cardiac MRI, Cardiac CT and Nuclear Cardiology at King Abdulaziz Medical City – Riyadh, University of British Columbia, University of Calgary and the University of Ottawa Heart Institute, Canada respectively. Dr Aljizeeri is board certified in Echocardiography, Cardiac CT, Nuclear Cardiology and Cardiac MRI.

Maryam Ahmed AlKhaja, working as a consultant radiologist and nuclear imaging specialist in the kingdom of Bahrain at Salmaniya Medical Complex and a clinical lecturer at Arabian gulf University. She has completed her residency training and board certification in Diagnostic imaging at Salmaniya Medical Complex. This was followed by completing a clinical fellowship program in nuclear imaging at the National University Hospital in Singapore, as nuclear imaging is her area of interest.

Dr. Ziad Farid Risheq is a nuclear medicine specialist with vast experience in nuclear hybrid imaging and subspecialty in cardiac imaging. He’s a board certified nuclear cardiologist and received extensive training in cardiovascular computed tomography in Johns Hopkins Bayview Medical Center in the U.S after which he completed his US board certification in Cardiovascular computed tomography. Dr. Ziad has special interest in myocardial perfusion/CT angiography hybrid imaging and was the first to introduce this modality in Jordan.

Consultant Medical Oncology, Head of GU &GY Unit Kuwait Cancer Control Center.
Prof. Of Clinical Oncology AL-Azhar University.
Master Degree Clinical Oncology 2004. pHD Clinical Oncology 2011. Clinical research diploma Harvard University 2016.
intersted in Genitourinary and Gynecology malignancy more than 10 year.
Member of ASCO, ESMO, ESGO, STIC and MASCC.
Have many publications in peer review Journals.